Function and regulation of the mitochondrial Sirtuin isoform Sirt5 in Mammalia

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 8, 2010, Pages 1658-1665

  Gertz, Melanie ^a   Steegborn, Clemens ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Deacetylase; Function; Metabolism; Mitochondria; Sirt5; Sirtuin

Indexed keywords

ANTINEOPLASTIC AGENT; CAMBINOL; EX 527; HYDROLASE INHIBITOR; ISOENZYME; ISONICOTINAMIDE; MITOCHONDRIAL ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 5; SURAMIN; UNCLASSIFIED DRUG;

ACETYLATION; AGING; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; CELLULAR DISTRIBUTION; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; LIFESPAN; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; MAMMAL CELL; METABOLIC REGULATION; MITOCHONDRION; MOLECULAR RECOGNITION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; LIGANDS; MAMMALS; MITOCHONDRIA; MODELS, MOLECULAR; PROTEIN CONFORMATION; SIRTUINS; STILBENES; SUBSTRATE SPECIFICITY; SURAMIN; TISSUE DISTRIBUTION;

MAMMALIA;

EID: 77953285831     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.09.011     Document Type: Review

References (66)

1. Blagosklonny M.V., Campisi J., and Sinclair D.A. Aging: past, present and future. Aging 1 (2009) 1-5
2. Guarente L. Sirtuins in aging and disease. Cold Spring Harb. Symp. Quant. Biol. 72 (2007) 483-488
3. Guarente L., and Picard F. Calorie restriction-the SIR2 connection. Cell 120 (2005) 473-482
4. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature 444 (2006) 868-874
5. Allfrey V.G., Faulkner R., and Mirsky A.E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. U.S.A. 51 (1964) 786-794
6. Glozak M.A., Sengupta N., Zhang X., and Seto E. Acetylation and deacetylation of non-histone proteins. Gene 363 (2005) 15-23
7. Yang X.J., and Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31 (2008) 449-461
8. Xu W.S., Parmigiani R.B., and Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26 (2007) 5541-5552
9. Holbert M.A., and Marmorstein R. Structure and activity of enzymes that remove histone modifications. Curr. Opin. Struct. Biol. 15 (2005) 673-680
10. Sauve A.A., Wolberger C., Schramm V.L., and Boeke J.D. The biochemistry of sirtuins. Annu. Rev. Biochem. 75 (2006) 435-465
11. J. Du, H. Jiang and H. Lin, Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogs and 32P-NAD, Biochemistry 48 (2009) 2878-2890.
12. Grubisha O., Smith B.C., and Denu J.M. Small molecule regulation of Sir2 protein deacetylases. FEBS J. 272 (2005) 4607-4616
13. Yang H., Yang T., Baur J.A., Perez E., Matsui T., Carmona J.J., Lamming D.W., Souza-Pinto N.C., Bohr V.A., Rosenzweig A., de Cabo R., Sauve A.A., and Sinclair D.A. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130 (2007) 1095-1107
14. Kaeberlein M., McVey M., and Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13 (1999) 2570-2580
15. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., and Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004) 390-392
16. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., Liu P., Mostoslavsky G., Franco S., Murphy M.M., Mills K.D., Patel P., Hsu J.T., Hong A.L., Ford E., Cheng H.L., Kennedy C., Nunez N., Bronson R., Frendewey D., Auerbach W., Valenzuela D., Karow M., Hottiger M.O., Hursting S., Barrett J.C., Guarente L., Mulligan R., Demple B., Yancopoulos G.D., and Alt F.W. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124 (2006) 315-329
17. Ford E., Voit R., Liszt G., Magin C., Grummt I., and Guarente L. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20 (2006) 1075-1080
18. Vaquero A., Scher M.B., Lee D.H., Sutton A., Cheng H.L., Alt F.W., Serrano L., Sternglanz R., and Reinberg D. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20 (2006) 1256-1261
19. North B.J., Marshall B.L., Borra M.T., Denu J.M., and Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell 11 (2003) 437-444
20. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., and Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16 (2005) 4623-4635
21. Guarente L. Mitochondria-a nexus for aging, calorie restriction, and sirtuins?. Cell 132 (2008) 171-176
22. Balaban R.S., Nemoto S., and Finkel T. Mitochondria, oxidants, and aging. Cell 120 (2005) 483-495
23. Acin-Perez R., Salazar E., Kamenetsky M., Buck J., Levin L.R., and Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 9 (2009) 265-276
24. Kamenetsky M., Middelhaufe S., Bank E.M., Levin L.R., Buck J., and Steegborn C. Molecular details of cAMP generation in mammalian cells: a tale of two systems. J. Mol. Biol. 362 (2006) 623-639
25. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., and Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23 (2006) 607-618
26. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., and Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10224-10229
27. Hallows W.C., Lee S., and Denu J.M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10230-10235
28. Ahn B.H., Kim H.S., Song S., Lee I.H., Liu J., Vassilopoulos A., Deng C.X., and Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 14447-14452
29. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., and Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 382 (2008) 790-801
30. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., Murphy A., Yang Y., Chen Y., Hirschey M.D., Bronson R.T., Haigis M., Guarente L.P., Farese Jr. R.V., Weissman S., Verdin E., and Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell Biol. 27 (2007) 8807-8814
31. Shi T., Wang F., Stieren E., and Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280 (2005) 13560-13567
32. Bellizzi D., Rose G., Cavalcante P., Covello G., Dato S., De Rango F., Greco V., Maggiolini M., Feraco E., Mari V., Franceschi C., Passarino G., and De Benedictis G. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85 (2005) 258-263
33. Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K., Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R., Alt F.W., and Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126 (2006) 941-954
34. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
35. Mahlknecht U., Ho A.D., Letzel S., and Voelter-Mahlknecht S. Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization. Cytogenet. Genome Res. 112 (2006) 208-212
36. Nakagawa T., Lomb D.J., Haigis M.C., and Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137 (2009) 560-570
37. Schwer B., North B.J., Frye R.A., Ott M., and Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 158 (2002) 647-657
38. Nakamura Y., Ogura M., Tanaka D., and Inagaki N. Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. Biochem. Biophys. Res. Commun. 366 (2008) 174-179
39. Borra M.T., Langer M.R., Slama J.T., and Denu J.M. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 43 (2004) 9877-9887
40. Cosgrove M.S., Bever K., Avalos J.L., Muhammad S., Zhang X., and Wolberger C. The structural basis of sirtuin substrate affinity. Biochemistry 45 (2006) 7511-7521
41. Khan A.N., and Lewis P.N. Unstructured conformations are a substrate requirement for the Sir2 family of NAD-dependent protein deacetylases. J. Biol. Chem. 280 (2005) 36073-36078
42. Pfister J.A., Ma C., Morrison B.E., and D'Mello S.R. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 3 (2008) e4090
43. Hagopian K., Ramsey J.J., and Weindruch R. Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. Exp. Gerontol. 38 (2003) 267-278
44. Lieber C.S., Leo M.A., Wang X., and Decarli L.M. Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem. Biophys. Res. Commun. 373 (2008) 246-252
45. Shepard B.D., and Tuma P.L. Alcohol-induced protein hyperacetylation: mechanisms and consequences. World J. Gastroenterol. 15 (2009) 1219-1230
46. Denu J.M. The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol. 9 (2005) 431-440
47. Schuetz A., Min J., Antoshenko T., Wang C.L., Allali-Hassani A., Dong A., Loppnau P., Vedadi M., Bochkarev A., Sternglanz R., and Plotnikov A.N. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 15 (2007) 377-389
48. L. Jin, W. Wei, Y. Jiang, H. Peng, J. Cai, C. Mao, H. Dai, W. Choy, J.E. Bemis, M.R. Jirousek, J.C. Milne, C.H. Westphal and R.B. Perni, Crystal structures of human SIRT3 displaying substrate-induced conformational changes, J. Biol. Chem. 284 (2009) 24394-24405.
49. Avalos J.L., Bever K.M., and Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol. Cell. 17 (2005) 855-868
50. Zhao K., Harshaw R., Chai X., and Marmorstein R. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8563-8568
51. Zhao K., Chai X., Clements A., and Marmorstein R. Structure and autoregulation of the yeast Hst2 homolog of Sir2. Nat. Struct. Biol. 10 (2003) 864-871
52. Neugebauer R.C., Sippl W., and Jung M. Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Curr. Pharm. Des. 14 (2008) 562-573
53. Kim E.J., Kho J.H., Kang M.R., and Um S.J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 28 (2007) 277-290
54. Milne J.C., and Denu J.M. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12 (2008) 11-17
55. Milne J.C., Lambert P.D., Schenk S., Carney D.P., Smith J.J., Gagne D.J., Jin L., Boss O., Perni R.B., Vu C.B., Bemis J.E., Xie R., Disch J.S., Ng P.Y., Nunes J.J., Lynch A.V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D.A., Olefsky J.M., Jirousek M.R., Elliott P.J., and Westphal C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450 (2007) 712-716
56. Heltweg B., Gatbonton T., Schuler A.D., Posakony J., Li H., Goehle S., Kollipara R., Depinho R.A., Gu Y., Simon J.A., and Bedalov A. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 66 (2006) 4368-4377
57. Neugebauer R.C., Uchiechowska U., Meier R., Hruby H., Valkov V., Verdin E., Sippl W., and Jung M. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. J. Med. Chem. 51 (2008) 1203-1213
58. Urbinati C., Chiodelli P., and Rusnati M. Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis. Molecules 13 (2008) 2758-2785
59. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., and Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
60. Taylor M.F., Bhattacharyya A.K., and Collins D.C. Inhibition of rat steroid 5 alpha-reductase (isozyme 1) by suramin. Steroids 60 (1995) 452-456
61. Trapp J., Meier R., Hongwiset D., Kassack M.U., Sippl W., and Jung M. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins). ChemMedChem 2 (2007) 1419-1431
62. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., and Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430 (2004) 686-689
63. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
64. Pirola L., and Frojdo S. Resveratrol: one molecule, many targets. IUBMB Life 60 (2008) 323-332
65. Sauve A.A., Moir R.D., Schramm V.L., and Willis I.M. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol. Cell 17 (2005) 595-601
66. Hoff K.G., Avalos J.L., Sens K., and Wolberger C. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide. Structure 14 (2006) 1231-1240